Colleen M Cunningham
Colleen M Cunningham
Assistant Professor of Strategy & Entrepreneurship, London Business School
Verified email at london.edu
Title
Cited by
Cited by
Year
The cost of drug development: a systematic review
S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson
Health policy 100 (1), 4-17, 2011
4262011
Killer acquisitions
C Cunningham, F Ederer, S Ma
922018
Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use
CM Cunningham, GE Hanley, S Morgan
Health policy 97 (2-3), 122-129, 2010
902010
Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in British Columbia, 1996 to 2006
S Morgan, C Cunningham
Healthcare Policy 7 (1), 68-79, 2011
362011
Information behaviour of Canadian pharmaceutical policy makers
DL Greyson, C Cunningham, S Morgan
Health Information & Libraries Journal 29 (1), 16-27, 2012
332012
Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data
S Morgan, G Hanley, C Cunningham, H Quan
Open Medicine 5 (2), e87, 2011
262011
The British Columbia Rx Atlas
S Morgan, C Cunningham, G Hanley, D Mooney
University of British Columbia. Centre for Health Services and Policy Research, 2009
222009
Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis
JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ...
Social psychiatry and psychiatric epidemiology 48 (12), 1861-1872, 2013
192013
Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British Columbia
SG Morgan, CM Cunningham, GE Hanley
PLoS One 5 (12), e15883, 2010
182010
The effect of evidence-based drug coverage policies on pharmaceutical R&D: A case study from British Columbia
S Morgan, C Cunningham
Healthcare Policy 3 (3), e128, 2008
142008
Income inequities in end-of-life health care spending in British Columbia, Canada: A cross-sectional analysis, 2004-2006
CM Cunningham, GE Hanley, SG Morgan
International Journal for Equity in Health 10 (1), 12, 2011
112011
Drug development: innovation or imitation deficit?
SG Morgan, CM Cunningham, MR Law
Bmj 345, 2012
102012
Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study
JH Puyat, GE Hanley, CM Cunningham, MR Law, ST Wong, ...
Psychiatric Services, 2011
102011
The limits of relational governance: Sales force strategies in the US medical device industry
AK Chatterji, CM Cunningham, JE Joseph
Strategic Management Journal, 2018
92018
Inventive capabilities in the division of innovative labor
A Arora, WM Cohen, CM Cunningham
National Bureau of Economic Research Working Paper Series, 2018
72018
When does novelty pay?
CM Cunningham
Academy of Management Proceedings 2017 (1), 16957, 2017
52017
Listening for prescriptions: a national consultation on pharmaceutical policy issues
S Morgan, CM Cunningham
Healthcare Policy 6 (2), 48, 2010
32010
Learning within Hierarchies: Corporate Proximity and Business Unit Response to Adverse Events
J Kim, C Cunningham, J Joseph
Academy of Management Proceedings 2020 (1), 16742, 2020
2020
Navigating Creative Destructions in the 21st Century: External Pressures and Resource Recombination
N Dutt, A Kapacinskaite, JA Nickerson, DP Ringov
Academy of Management Proceedings 2020 (1), 16681, 2020
2020
Advanced Technology and Creative Magic: How Technology Use Shapes the Creativity-Innovation Process
C Cunningham, H Lifshitz-Assaf, E Truelove, A Vardanyan
Academy of Management Proceedings 2020 (1), 13851, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20